Skip to content
Tuesday, November 17, 2026
Urban Logs

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Package Over Data Apprehensions

Health funding illustration
The proposed US funding was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a significant US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's request for sensitive data.

The decision became public after a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".

An official spokesman later explained that the United States was requesting biological samples for scientific study and commercial gain while refused to share the resulting advantages from any future vaccines.

"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has called for further negotiations to find a deal acceptable to both sides so the country's vital HIV treatment initiative can proceed.

Wider Implications

Zimbabwe's decision follows a comparable case in Kenya, where a court suspended a similar deal with the US following legal challenges were filed about the safety of citizens' medical information.

After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.

According to reports, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Rejected Deal

The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this cooperation might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"Our nation was requested to surrender its biological resources and data for a long time, without any corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.

"Effectively, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be available to our population should a future health crisis arise."

National Interest and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were upending frameworks already set up via the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.

"This system is designed to guarantee that when a country provides its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."

These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome continued dialogue with our American counterparts on how future collaboration might be structured in a manner that respects the independence and dignity of each country."

Medical Community Response

A leading public health body said it recognised the official position, but suggested that negotiations must proceed considering much of the nation's HIV programmes relied on foreign aid.

"Where technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.

The halted deal underscores the complex challenges between accepting much-needed international aid and protecting a country's data in an ever more data-driven world.

By

Cody Glenn

A freelance writer and photographer documenting urban life and hidden city gems with a passion for storytelling.

Urban Logs

Type to search articles.